Could combinatorial CAR-T approaches lead to curative therapy for multiple myeloma?

Описание к видео Could combinatorial CAR-T approaches lead to curative therapy for multiple myeloma?

Joshua Richter, MD, Mount Sinai Medical Center, New York, NY, discusses whether combining CAR T-cell therapies with other therapeutics such as gamma secretase inhibitors or checkpoint inhibitors could lead to the development of a curative CAR-T strategy, which is currently an unmet need for patients with multiple myeloma (MM). This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Комментарии

Информация по комментариям в разработке

Похожие видео